J&J

News

US court tells J&J to pay $8bn damages to man over breast gr...

A court has told Johnson & Johnson to pay $8 billion in punitive damages to a man who said he was not warned that an antipsychotic drug could lead to breast growth.

Digital

Making behaviour change stick

Behaviour change is set to become a key skill for pharma companies in the very near future – an essential beyond-the-pill strategy, often delivered via digital tech, that can help keep peop

Views & Analysis

The science of prevention

'Prevention' might be the buzzword of the moment in the pharma industry, but what does it actually mean for a company to intercept diseases before they even present clinically?

News

Teva settles Oklahoma opioid lawsuit ahead of trial

Teva has opted to settle the first trial among hundreds of cases that accuse it and other drugmakers of helping to fuel the opioid addiction epidemic in the US.

Views & Analysis

Shifting the paradigm from “disease care” to health care

Cat Oyler, vice president, global public health, tuberculosis at Johnson & Johnson, explains that by shifting focus to prevention, we can help to both reduce pressure on an increasingly

News